Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Updated Prevalence of mcr-Like Genes among Escherichia coli and Klebsiella pneumoniae in the SENTRY Program and Characterization of mcr-1.11 Variant.

Deshpande LM, Hubler C, Davis AP, Castanheira M.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02450-18. doi: 10.1128/AAC.02450-18. Print 2019 Apr. No abstract available.

PMID:
30917984
2.

Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program.

Castanheira M, Deshpande LM, Mendes RE, Canton R, Sader HS, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S23-S33. doi: 10.1093/ofid/ofy347. eCollection 2019 Mar.

3.

Aminoglycoside-modifying enzyme and 16S ribosomal RNA methyltransferase genes among a global collection of Gram-negative isolates.

Costello SE, Deshpande LM, Davis AP, Mendes RE, Castanheira M.

J Glob Antimicrob Resist. 2019 Mar;16:278-285. doi: 10.1016/j.jgar.2018.10.020. Epub 2018 Oct 30.

PMID:
30389638
4.
5.

Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program.

Deshpande LM, Castanheira M, Flamm RK, Mendes RE.

J Antimicrob Chemother. 2018 Sep 1;73(9):2314-2322. doi: 10.1093/jac/dky188.

PMID:
29878213
6.

Case report of transient mcr-1-haboring Escherichia coli with concurrent Staphylococcus aureus bacteremia in Long Beach, California.

Le J, Turner N, Deshpande LM, Davis AP, Castanheira M.

Diagn Microbiol Infect Dis. 2017 Dec;89(4):303-304. doi: 10.1016/j.diagmicrobio.2017.07.005. Epub 2017 Jul 14.

PMID:
28987268
7.

Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.

Castanheira M, Deshpande LM, Davis AP, Rhomberg PR, Pfaller MA.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00906-17. doi: 10.1128/AAC.00906-17. Print 2017 Oct.

8.

Empyema thoracis caused by an optrA-positive and linezolid-intermediate Enterococcus faecalis strain.

Chien JY, Mendes RE, Deshpande LM, Hsueh PR.

J Infect. 2017 Aug;75(2):182-184. doi: 10.1016/j.jinf.2017.05.003. Epub 2017 May 13. No abstract available.

PMID:
28506787
9.

Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015.

Castanheira M, Griffin MA, Deshpande LM, Mendes RE, Jones RN, Flamm RK.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5623-4. doi: 10.1128/AAC.01267-16. Print 2016 Sep. No abstract available.

10.

High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center.

Aitken SL, Tarrand JJ, Deshpande LM, Tverdek FP, Jones AL, Shelburne SA, Prince RA, Bhatti MM, Rolston KVI, Jones RN, Castanheira M, Chemaly RF.

Clin Infect Dis. 2016 Oct 1;63(7):954-958. doi: 10.1093/cid/ciw398. Epub 2016 Jun 16.

PMID:
27313265
11.

Klebsiella pneumoniae Isolate from a New York City Hospital Belonging to Sequence Type 258 and Carrying blaKPC-2 and blaVIM-4.

Castanheira M, Deshpande LM, Mills JC, Jones RN, Soave R, Jenkins SG, Schuetz AN.

Antimicrob Agents Chemother. 2016 Jan 4;60(3):1924-7. doi: 10.1128/AAC.01844-15.

12.

Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program.

Deshpande LM, Ashcraft DS, Kahn HP, Pankey G, Jones RN, Farrell DJ, Mendes RE.

Antimicrob Agents Chemother. 2015 Oct;59(10):6256-61. doi: 10.1128/AAC.01473-15. Epub 2015 Jul 27.

13.

Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.

Mendes RE, Deshpande LM, Costello AJ, Farrell DJ, Jones RN, Flamm RK.

Microb Drug Resist. 2016 Jan;22(1):53-8. doi: 10.1089/mdr.2014.0307. Epub 2015 Jul 31.

14.
15.

MSSA ST398/t034 carrying a plasmid-mediated Cfr and Erm(B) in Brazil.

Gales AC, Deshpande LM, de Souza AG, Pignatari AC, Mendes RE.

J Antimicrob Chemother. 2015 Jan;70(1):303-5. doi: 10.1093/jac/dku366. Epub 2014 Sep 26. No abstract available.

PMID:
25261421
16.

Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.

Mendes RE, Deshpande LM, Jones RN.

Drug Resist Updat. 2014 Apr;17(1-2):1-12. doi: 10.1016/j.drup.2014.04.002. Epub 2014 Apr 6. Review.

PMID:
24880801
17.

Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.

Castanheira M, Deshpande LM, Costello A, Davies TA, Jones RN.

J Antimicrob Chemother. 2014 Jul;69(7):1804-14. doi: 10.1093/jac/dku048. Epub 2014 Mar 5.

PMID:
24603963
18.

Detection of NDM-1-producing Enterobacteriaceae in Romania: report of the SENTRY Antimicrobial Surveillance Program.

Deshpande LM, Flonta M, Jones RN, Castanheira M.

J Med Microbiol. 2014 Mar;63(Pt 3):483-4. doi: 10.1099/jmm.0.070334-0. Epub 2013 Dec 17. No abstract available.

PMID:
24346066
19.

Retrospective molecular analysis of DIM-1 metallo-β-lactamase discovered in Pseudomonas stutzeri from India in 2000.

Deshpande LM, Jones RN, Woosley LN, Castanheira M.

Antimicrob Agents Chemother. 2014;58(1):596-8. doi: 10.1128/AAC.01541-13. Epub 2013 Oct 21.

20.

IMP-33, a New IMP variant detected in Pseudomonas aeruginosa from Sicily.

Deshpande LM, Davies TA, Blandino G, Nicoletti G, Jones RN, Castanheira M.

Antimicrob Agents Chemother. 2013 Dec;57(12):6401-3. doi: 10.1128/AAC.02532-12. Epub 2013 Sep 16. No abstract available.

21.

Streptococcus sanguinis isolate displaying a phenotype with cross-resistance to several rRNA-targeting agents.

Mendes RE, Deshpande LM, Kim J, Myers DS, Ross JE, Jones RN.

J Clin Microbiol. 2013 Aug;51(8):2728-31. doi: 10.1128/JCM.00757-13. Epub 2013 May 22.

22.

Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010).

Castanheira M, Farrell SE, Deshpande LM, Mendes RE, Jones RN.

Antimicrob Agents Chemother. 2013 Jul;57(7):3012-20. doi: 10.1128/AAC.02252-12. Epub 2013 Apr 15.

23.

Dissemination of a pSCFS3-like cfr-carrying plasmid in Staphylococcus aureus and Staphylococcus epidermidis clinical isolates recovered from hospitals in Ohio.

Mendes RE, Deshpande LM, Bonilla HF, Schwarz S, Huband MD, Jones RN, Quinn JP.

Antimicrob Agents Chemother. 2013 Jul;57(7):2923-8. doi: 10.1128/AAC.00071-13. Epub 2013 Apr 9.

24.

Update on the prevalence and genetic characterization of NDM-1-producing Enterobacteriaceae in Indian hospitals during 2010.

Castanheira M, Deshpande LM, Farrell SE, Shetye S, Shah N, Jones RN.

Diagn Microbiol Infect Dis. 2013 Feb;75(2):210-3. doi: 10.1016/j.diagmicrobio.2012.10.017. Epub 2012 Nov 22.

PMID:
23177221
25.

Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.

Mendes RE, Deshpande LM, Smyth DS, Shopsin B, Farrell DJ, Jones RN.

J Clin Microbiol. 2012 Nov;50(11):3694-702. doi: 10.1128/JCM.02024-12. Epub 2012 Sep 12.

26.

Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.

Mendes RE, Deshpande LM, Costello AJ, Farrell DJ.

Antimicrob Agents Chemother. 2012 Sep;56(9):4656-61. doi: 10.1128/AAC.00279-12. Epub 2012 Jun 11.

27.

Expansion of clonal complex 258 KPC-2-producing Klebsiella pneumoniae in Latin American hospitals: report of the SENTRY Antimicrobial Surveillance Program.

Castanheira M, Costello AJ, Deshpande LM, Jones RN.

Antimicrob Agents Chemother. 2012 Mar;56(3):1668-9; author reply 1670-1. doi: 10.1128/AAC.05942-11. No abstract available.

28.

Evaluation of quinolone resistance-determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones.

Castanheira M, Deshpande LM, Jones RN, Farrell DJ.

Diagn Microbiol Infect Dis. 2012 Mar;72(3):263-6. doi: 10.1016/j.diagmicrobio.2011.12.001.

PMID:
22321998
29.

Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007.

Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE.

Antimicrob Agents Chemother. 2011 Mar;55(3):1274-8. doi: 10.1128/AAC.01497-10. Epub 2010 Dec 28.

30.

Comment on: role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases.

Castanheira M, Deshpande LM, Mendes RE, Rodriguez-Noriega E, Jones RN, Morfin-Otero R.

J Antimicrob Chemother. 2011 Mar;66(3):684-5; author reply 686. doi: 10.1093/jac/dkq393. Epub 2010 Oct 20. No abstract available.

PMID:
20961909
31.

Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy.

Mendes RE, Deshpande LM, Farrell DJ, Spanu T, Fadda G, Jones RN.

J Antimicrob Chemother. 2010 Nov;65(11):2329-35. doi: 10.1093/jac/dkq331. Epub 2010 Sep 14.

PMID:
20841419
32.

Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.

Mendes RE, Sader HS, Deshpande LM, Diep BA, Chambers HF, Jones RN.

J Clin Microbiol. 2010 Feb;48(2):568-74. doi: 10.1128/JCM.01384-09. Epub 2009 Nov 25.

33.
34.

Daptomycin activity tested against linezolid-nonsusceptible gram-positive clinical isolates.

Mendes RE, Jones RN, Deshpande LM, Ross JE, Sader HS.

Microb Drug Resist. 2009 Dec;15(4):245-9. doi: 10.1089/mdr.2009.0045.

PMID:
19857129
35.

First descriptions of blaKPC in Raoultella spp. (R. planticola and R. ornithinolytica): report from the SENTRY Antimicrobial Surveillance Program.

Castanheira M, Deshpande LM, DiPersio JR, Kang J, Weinstein MP, Jones RN.

J Clin Microbiol. 2009 Dec;47(12):4129-30. doi: 10.1128/JCM.01502-09. Epub 2009 Oct 7.

36.

Dissemination of a bla(VIM-2)-carrying integron among Enterobacteriaceae species in Mexico: report from the SENTRY Antimicrobial Surveillance Program.

Morfin-Otero R, Rodriguez-Noriega E, Deshpande LM, Sader HS, Castanheira M.

Microb Drug Resist. 2009 Mar;15(1):33-5. doi: 10.1089/mdr.2009.0878.

PMID:
19228113
37.

Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites.

Gur D, Korten V, Unal S, Deshpande LM, Castanheira M.

J Med Microbiol. 2008 Dec;57(Pt 12):1529-32. doi: 10.1099/jmm.0.2008/002469-0.

PMID:
19018025
38.

Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program.

Mendes RE, Bell JM, Turnidge JD, Castanheira M, Deshpande LM, Jones RN.

Antimicrob Agents Chemother. 2009 Feb;53(2):843-4. doi: 10.1128/AAC.00999-08. Epub 2008 Nov 17. No abstract available.

39.

Emergence and clonal dissemination of OXA-24- and OXA-58-producing Acinetobacter baumannii strains in Houston, Texas: report from the SENTRY Antimicrobial Surveillance Program.

Castanheira M, Wanger A, Kruzel M, Deshpande LM, Jones RN.

J Clin Microbiol. 2008 Sep;46(9):3179-80. doi: 10.1128/JCM.00988-08. No abstract available.

40.

First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.

Mendes RE, Deshpande LM, Castanheira M, DiPersio J, Saubolle MA, Jones RN.

Antimicrob Agents Chemother. 2008 Jun;52(6):2244-6. doi: 10.1128/AAC.00231-08. Epub 2008 Apr 7.

41.

IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico.

Martin CA, Morita K, Ribes JA, Deshpande LM, Sader HS, Castanheira M.

Antimicrob Agents Chemother. 2008 Jun;52(6):2289-90. doi: 10.1128/AAC.00299-08. Epub 2008 Mar 24. No abstract available.

43.

Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006).

Rhomberg PR, Deshpande LM, Kirby JT, Jones RN.

Diagn Microbiol Infect Dis. 2007 Dec;59(4):425-32. Epub 2007 Jul 26.

PMID:
17662557
44.

Molecular characterization of Staphylococcus aureus isolates from a 2005 clinical trial of uncomplicated skin and skin structure infections.

Jones RN, Nilius AM, Akinlade BK, Deshpande LM, Notario GF.

Antimicrob Agents Chemother. 2007 Sep;51(9):3381-4. Epub 2007 Jun 18.

45.

Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program.

Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN.

Diagn Microbiol Infect Dis. 2007 Jun;58(2):163-70. Epub 2007 Mar 26.

PMID:
17368801
46.
47.

blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program.

Aboufaycal H, Sader HS, Rolston K, Deshpande LM, Toleman M, Bodey G, Raad I, Jones RN.

J Clin Microbiol. 2007 Feb;45(2):614-5. Epub 2006 Dec 6.

48.

Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).

Deshpande LM, Jones RN, Fritsche TR, Sader HS.

Int J Antimicrob Agents. 2006 Dec;28(6):578-81. Epub 2006 Nov 16.

PMID:
17112706
50.

Supplemental Content

Loading ...
Support Center